Journey Medical (DERM) FCF Margin Growth (1y) (2021 - 2026)
Journey Medical (DERM) FCF Margin Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 427.00 |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 325.00 |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -892.00 |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 1,003.00 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 410.00 |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 39.00 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 333.00 |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Journey Medical | 206.75 Mn | 181.11 Mn | 12.37 Mn | -309.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -309.00 |
| Mar 31, 2026 | 3,983.00 |
| Dec 31, 2025 | -5,671.00 |
| Sep 30, 2025 | -609.00 |
| Jun 30, 2025 | 2,857.00 |
| Mar 31, 2025 | 1,696.00 |
| Dec 31, 2024 | 12,591.00 |
| Sep 30, 2024 | -6,219.00 |
| Jun 30, 2024 | -5,824.00 |
| Mar 31, 2024 | 1,044.00 |
| Dec 31, 2023 | -8,418.00 |
| Sep 30, 2023 | 9,946.00 |
| Jun 30, 2023 | 4,144.00 |
| Mar 31, 2023 | 4,296.00 |
| Dec 31, 2022 | -579.00 |
| Sep 30, 2022 | -8,140.00 |
| Jun 30, 2022 | 3,061.00 |
| Mar 31, 2022 | -10,462.00 |
| Dec 31, 2021 | -2,493.00 |